ketanserin has been researched along with Weight Loss in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Weight Loss: Decrease in existing BODY WEIGHT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haahr, ME | 1 |
| Hansen, DL | 1 |
| Fisher, PM | 1 |
| Svarer, C | 1 |
| Stenbæk, DS | 1 |
| Madsen, K | 1 |
| Madsen, J | 1 |
| Holst, JJ | 1 |
| Baaré, WF | 1 |
| Hojgaard, L | 1 |
| Almdal, T | 1 |
| Knudsen, GM | 1 |
1 other study available for ketanserin and Weight Loss
| Article | Year |
|---|---|
Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals.
Topics: Adult; Body Mass Index; Brain; Brain Mapping; Case-Control Studies; Denmark; Female; Gastric Bypass; | 2015 |